@TacticzH TacticzH
Transparent AI-buildout supply-chain generalist who ranks moats and watches valuation
Shares an original, moat-ranked thesis on the AI capex value
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY. · Analyst brief as of 2026-06-22.
Across their last 20 scored bets: 60% hit rate, +3.45% mean alpha, trader score +2.02. Their last-14d mentions, direction-adjusted, have moved +5.9% since posting (mean over 53 mentions with price data).
This author is mainly constructive on NVO, arguing Wegovy pill catalysts and China filings could support a turnaround while pressuring LLY. They are sharply bearish on SPCX valuation and retail risk, and more broadly skeptical that AI-buildout leverage and value-chain optimism will hold if conditions turn. No CALL_DIRECTIONAL or POSITION_DISCLOSURE signals indicate explicit adds, trims, exits, or flips in this payload.
Conviction is concentrated in a constructive NVO turnaround thesis, with LLY framed mostly as the competitive loser in Novo's pill-led GLP-1 push. Bearishness is also clear on SPCX, where the author rejects valuation and margin quality, while broader AI commentary is cautious around OpenAI economics, leverage, and memory-chain risk. No explicit adds, trims, exits, or position flips appear in the eligible signal types.
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-07-03 | ASML | @TacticzH | +0.35 | Jefferies raised ASML PT to €1560 from €1260 and kept Hold, with revenue/guidance estimates. | — | tweet ↗ |
| 2026-07-02 | · | @TacticzH | · | States software has peaked, a bearish sector-level call. | · | tweet ↗ |
| 2026-07-01 | · | @TacticzH | · | Discloses portfolio up 35% in last 3 months and positioning toward EM/software. | · | tweet ↗ |
| 2026-06-30 | NVDA | @TacticzH | +0.00 | Nuanced CCXI thesis: real product and partners but weak financial disclosure and high valuation. | -2.6% | tweet ↗ |
| 2026-06-30 | AMZN | @TacticzH | +0.00 | Nuanced CCXI thesis: real product and partners but weak financial disclosure and high valuation. | +1.8% | tweet ↗ |
| 2026-06-30 | MELI | @TacticzH | +0.00 | Nuanced CCXI thesis: real product and partners but weak financial disclosure and high valuation. | +3.9% | tweet ↗ |
| 2026-06-30 | CCXI | @TacticzH | -0.25 | Nuanced CCXI thesis: real product and partners but weak financial disclosure and high valuation. | · | tweet ↗ |
| 2026-06-30 | ASML | @TacticzH | -0.20 | Does not like ASML buybacks at current level despite all-time high. | -11.1% | tweet ↗ |
| 2026-06-30 | CCXI | @TacticzH | -0.55 | Says CCXI is not an easy buy, not interested after run-up and weak financial visibility. | · | tweet ↗ |
| 2026-06-30 | CCXI | @TacticzH | +0.20 | Positive wrapper on CCXI content but analysis is in linked context. | · | tweet ↗ |
| 2026-06-29 | AMD | @TacticzH | +0.25 | Physical AI value-chain basket listing companies by layer. | -4.0% | tweet ↗ |
| 2026-06-29 | QCOM | @TacticzH | +0.25 | Physical AI value-chain basket listing companies by layer. | -6.6% | tweet ↗ |
| 2026-06-29 | TSM | @TacticzH | +0.25 | Physical AI value-chain basket listing companies by layer. | -4.6% | tweet ↗ |
| 2026-06-29 | NVDA | @TacticzH | +0.25 | Physical AI value-chain basket listing companies by layer. | -0.1% | tweet ↗ |
| 2026-06-29 | AVGO | @TacticzH | +0.25 | Physical AI value-chain basket listing companies by layer. | -3.2% | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.